Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Cadila Healthcare:...

    Cadila Healthcare: Plan of raising Rs 18 500 cr through shares and securities

    Written by savita thakur thakur Published On 2016-05-02T14:04:10+05:30  |  Updated On 2 May 2016 2:04 PM IST
    Cadila Healthcare: Plan of raising Rs 18 500 cr through shares and securities

    New Delhi : Zydus Cadila group firm Cadila Healthcare said it is planning to raise up to Rs 18,500 crore through issuance of shares and various other securities.


    The board of directors at its meeting to be held on May 13, 2016, will consider raising funds through various options, the company said in a BSE filing.


    The options include issuance of equity shares, convertible bonds, debentures through qualified institutional placement (QIP), GDR, ADR for an aggregate amount of up to Rs 10,000 crore.


    Moreover, the board will also consider raising up to Rs 3,500 crore in the 2016-17 fiscal by issuing secured/unsecured redeemable non-convertible debentures on a private placement basis.


    It will also consider issuing secured/unsecured foreign currency rated bonds/foreign currency convertible bonds for an amount up to Rs 5,000 crore, the filing added.


    Headquartered in Ahmedabad, Zydus Cadila group has global operations in four continents spread across the US, Europe, Latin America and South Africa and 25 other emerging markets.


    The group's operations cover healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products. AKT RKL PRB MKJ

    Active Pharmaceutical IngredientADRbondsCadila Healthcareconvertible bondsdebenturesequity sharesGDRQIPqualified institutional placementsZydus Cadila
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok